C

Cryo-Cell International Inc
AMEX:CCEL

Watchlist Manager
Cryo-Cell International Inc
AMEX:CCEL
Watchlist
Price: 7.72 USD -1.03% Market Closed
Market Cap: 62.2m USD
Have any thoughts about
Cryo-Cell International Inc?
Write Note

Cash Flow Statement

Cash Flow Statement
Cryo-Cell International Inc

Rotate your device to view
Cash Flow Statement
Currency: USD
Aug-2014 Nov-2014 Feb-2015 May-2015 Aug-2015 Nov-2015 Feb-2016 May-2016 Aug-2016 Nov-2016 Feb-2017 May-2017 Aug-2017 Nov-2017 Feb-2018 May-2018 Aug-2018 Nov-2018 Feb-2019 May-2019 Aug-2019 Nov-2019 Feb-2020 May-2020 Aug-2020 Nov-2020 Feb-2021 May-2021 Aug-2021 Nov-2021 Feb-2022 May-2022 Aug-2022 Nov-2022 Feb-2023 May-2023 Aug-2023 Nov-2023 Feb-2024 May-2024 Aug-2024
Operating Cash Flow
Net Income
1
1
0
0
8
8
8
8
(2)
(1)
(1)
(1)
2
2
(1)
(1)
(1)
(1)
2
1
2
2
3
4
3
4
4
4
4
2
2
2
1
3
3
2
3
(10)
(10)
(9)
(9)
Depreciation & Amortization
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Change in Deffered Taxes
0
0
0
0
(7)
(7)
0
0
(1)
(2)
0
(2)
(1)
(1)
2
2
(1)
2
0
0
0
(2)
0
0
0
(1)
0
0
0
(2)
0
0
0
(2)
0
0
0
(7)
0
0
0
Other Non-Cash Items
2
2
2
2
1
2
2
2
7
6
6
7
2
1
2
1
1
1
1
3
3
3
2
1
3
2
2
1
(0)
2
1
2
3
2
2
2
2
18
18
18
17
Cash Taxes Paid
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
2
2
2
2
2
2
3
3
Cash Interest Paid
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
2
1
2
2
2
2
2
Change in Working Capital
(2)
(1)
(1)
0
1
2
2
1
1
2
2
2
3
3
4
2
4
2
3
2
1
2
3
4
2
4
4
5
6
5
3
4
4
4
4
4
4
6
4
4
5
Cash from Operating Activities
1
N/A
2
+21%
2
+28%
3
+52%
3
+3%
5
+56%
5
-5%
4
-6%
4
+1%
5
+13%
5
+7%
6
+13%
6
+2%
6
-7%
7
+22%
5
-28%
7
+30%
5
-19%
5
+3%
6
+9%
6
0%
6
+6%
7
+12%
7
+4%
7
-9%
8
+27%
9
+1%
9
+8%
9
+0%
8
-14%
7
-15%
7
+6%
8
+9%
9
+10%
9
+2%
9
+0%
8
-9%
9
+11%
7
-22%
7
-3%
7
+7%
Investing Cash Flow
Capital Expenditures
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(1)
(1)
(1)
(1)
(0)
(1)
(1)
(1)
(1)
(0)
(0)
(0)
(0)
(0)
(2)
(2)
(2)
(3)
(12)
(12)
(12)
(13)
(5)
(7)
(7)
(7)
(4)
Other Items
1
1
1
(0)
(0)
(1)
(1)
(0)
(0)
(0)
0
0
0
0
0
0
(11)
(11)
0
0
(0)
(0)
0
0
0
0
0
(5)
(5)
(5)
(10)
(5)
(5)
(3)
1
1
1
(1)
(0)
(1)
(2)
Cash from Investing Activities
1
N/A
0
-46%
0
+25%
(0)
N/A
(1)
-61%
(1)
-36%
(1)
-24%
(1)
+11%
(1)
+32%
(0)
+32%
(0)
+86%
0
N/A
0
-64%
0
+133%
(1)
N/A
(1)
-6%
(11)
-1 942%
(11)
0%
(11)
+4%
(11)
-3%
(1)
+95%
(1)
-20%
(1)
+6%
(0)
+49%
0
N/A
0
+195%
0
-43%
(5)
N/A
(7)
-40%
(7)
-5%
(13)
-85%
(8)
+39%
(17)
-124%
(15)
+13%
(10)
+32%
(12)
-16%
(4)
+65%
(8)
-92%
(7)
+11%
(8)
-16%
(6)
+32%
Financing Cash Flow
Net Issuance of Common Stock
(2)
(3)
(2)
(2)
(3)
(3)
(4)
(3)
(11)
(11)
(10)
(11)
(1)
(0)
(0)
(0)
0
0
0
0
0
(1)
(1)
(1)
(1)
0
0
1
1
1
0
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
Net Issuance of Debt
0
0
0
0
(0)
(0)
(0)
(0)
6
6
5
5
(3)
(3)
(3)
(3)
7
6
5
5
(5)
(4)
(4)
(4)
(5)
(5)
(6)
(6)
(4)
(4)
(3)
(3)
6
9
10
10
3
(1)
0
2
(1)
Cash Paid for Dividends
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(8)
0
0
0
0
0
0
0
Other
0
0
0
0
0
0
0
0
0
(0)
0
0
0
0
0
0
0
(0)
0
0
0
(0)
0
0
(0)
(0)
0
0
0
0
0
0
(0)
(0)
0
(0)
(0)
(0)
0
0
0
Cash from Financing Activities
(2)
N/A
(3)
-14%
(2)
+16%
(2)
N/A
(3)
-52%
(3)
+2%
(4)
-14%
(3)
+19%
(5)
-53%
(5)
-15%
(5)
-2%
(6)
-11%
(4)
+40%
(3)
+15%
(3)
+2%
(3)
+10%
7
N/A
6
-18%
5
-5%
5
-5%
(5)
N/A
(5)
-1%
(5)
+1%
(5)
N/A
(6)
-19%
(5)
+17%
(6)
-17%
(5)
+15%
(3)
+39%
(3)
-1%
(3)
+0%
(5)
-48%
5
N/A
0
-97%
1
+540%
2
+75%
(6)
N/A
(2)
+66%
(1)
+63%
1
N/A
(2)
N/A
Change in Cash
Net Change in Cash
(0)
N/A
(1)
-148%
0
N/A
1
+70%
(1)
N/A
1
N/A
0
-97%
1
+1 867%
(1)
N/A
(1)
+7%
(0)
+88%
0
N/A
3
+1 295%
3
+5%
3
+26%
2
-48%
2
+30%
(0)
N/A
0
N/A
(0)
N/A
0
N/A
1
+68%
1
+167%
2
+46%
1
-61%
4
+397%
3
-25%
(0)
N/A
(0)
+14%
(2)
-416%
(9)
-335%
(5)
+44%
(5)
+7%
(7)
-37%
(1)
+88%
(2)
-118%
(2)
-39%
(1)
+45%
(1)
+13%
(1)
+42%
(0)
+41%
Free Cash Flow
Free Cash Flow
1
N/A
1
+34%
2
+30%
3
+58%
3
+3%
5
+57%
5
-5%
4
-11%
4
+1%
5
+15%
5
+8%
6
+19%
6
+2%
6
-8%
6
+14%
5
-30%
6
+32%
5
-21%
5
+12%
5
+3%
5
+1%
6
+4%
6
+14%
7
+9%
6
-8%
8
+29%
8
+0%
9
+9%
8
-17%
6
-20%
4
-29%
4
+3%
(5)
N/A
(4)
+23%
(3)
+11%
(4)
-35%
3
N/A
2
-28%
(0)
N/A
(1)
-23 836%
3
N/A

See Also

Discover More